Spots Global Cancer Trial Database for refractory or intolerant to mycosis fungoides and sezary syndrome
Every month we try and update this database with for refractory or intolerant to mycosis fungoides and sezary syndrome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome | NCT00127881 | Mycosis Fungoid... Sezary Syndrome | HuMax-CD4 (zano... | 18 Years - | Emergent Product Development Seattle LLC | |
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome | NCT00127881 | Mycosis Fungoid... Sezary Syndrome | HuMax-CD4 (zano... | 18 Years - | Emergent Product Development Seattle LLC | |
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome | NCT00127881 | Mycosis Fungoid... Sezary Syndrome | HuMax-CD4 (zano... | 18 Years - | Emergent Product Development Seattle LLC | |
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome | NCT00127881 | Mycosis Fungoid... Sezary Syndrome | HuMax-CD4 (zano... | 18 Years - | Emergent Product Development Seattle LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
